FTV.NYSEFortive CORP

10-Q: Fortive Reports Q2 Decline Amid Strategic Separation and Restructuring Costs

Sentiment:

Quarterly Report


Fortive Corporation reported a decrease in sales and net earnings for the second quarter and year-to-date periods of 2025, impacted by volume declines, higher costs, and significant expenses related to the Precision Technologies segment separation.

Capital raiseRalliant Corporation, a former wholly-owned subsidiary, borrowed $1.15 billion in aggregate principal amount consisting of a USD Term Loan due 2026 and a USD Term Loan due 2028 on June 27, 2025.The proceeds from this Ralliant Debt were used to fund a $1.15 billion cash dividend from Ralliant to Fortive prior to the Distribution Date of the separation.
Worse than expectedTotal sales decreased by 2.2% in Q2 2025 and 2.7% year-to-date compared to the prior year periods.Core revenue declined by 2.5% in Q2 2025 and 2.1% year-to-date, indicating underlying business contraction.Net earnings decreased by 14.6% in Q2 2025 and 15.9% year-to-date.Operating profit decreased significantly by 26.4% in Q2 2025 and 24.5% year-to-date, with operating profit margins declining by 480 and 440 basis points respectively.Increased Selling, General and Administrative (SG&A) expenses due to Separation-related costs and higher employee compensation contributed to the profit decline.Volume declines across segments, particularly in Precision Technologies, negatively impacted sales and profitability.

Summary

  • Total sales for the three months ended June 27, 2025, decreased by 2.2% to $1,518.8 million, compared to $1,552.4 million in the prior year period.
  • Core revenue for the second quarter declined by 2.5%, driven by a 5.4% decrease in volume, partially offset by 2.9% favorable pricing.
  • Net earnings for the second quarter were $166.6 million, a 14.6% decrease from $195.1 million in the comparable prior year period.
  • Diluted earnings per share (EPS) for the second quarter was $0.49, down from $0.55 in the prior year.
  • Operating profit for the second quarter decreased by 26.4% to $222.2 million, with the operating profit margin falling 480 basis points to 14.6%.
  • Year-to-date sales decreased by 2.7% to $2,993.0 million, with core revenue declining by 2.1%.
  • Year-to-date net earnings were $338.5 million, a 15.9% decrease from $402.5 million in the prior year period.
  • Year-to-date diluted EPS was $0.99, down from $1.13 in the prior year.
  • Operating cash flows for the six months ended June 27, 2025, were $552.9 million, a slight decrease from $565.6 million in the comparable period of 2024.
  • The Precision Technologies (PT) segment separation was completed on June 28, 2025, with Ralliant Corporation being distributed to Fortive shareholders; Ralliant will be classified as a discontinued operation from Q3 2025.
  • Incurred $41 million in Separation-related costs during the second quarter and $64 million year-to-date, primarily for professional fees and redundant general and administrative costs.
  • The company acquired EA Elektro-Automatik Holding GmbH on January 3, 2024, for approximately $1.72 billion, adding $1.18 billion in goodwill to the PT segment.
  • A discrete restructuring plan initiated in Q4 2024, primarily involving workforce reductions related to the Separation, incurred charges of $8 million in Q2 2025 and $12 million year-to-date.
  • Cash and equivalents increased significantly to $1,832.7 million as of June 27, 2025, up from $813.3 million at December 31, 2024, partly due to proceeds from Ralliant's debt issuance.
  • Repurchased 1.9 million shares of common stock at an average price of $71.15 in Q2 2025, and 4.4 million shares at an average price of $76.76 year-to-date.
  • The Board authorized an additional 15.6 million shares for repurchase under the general program and a separate special purpose program for up to $550 million using Ralliant Dividend proceeds.

Sentiment

Score: 4

Explanation: The company experienced significant declines in sales, net earnings, and operating profit, driven by volume reductions and substantial separation-related costs. While strategic actions like the PT separation and share repurchases are underway, the immediate financial performance is weaker, indicating a challenging period.

Positives

  • Interest expense, net, decreased by 17.1% in Q2 2025 and 22.5% year-to-date, primarily due to a favorable debt mix with lower fixed rates and reduced floating rates.
  • Cash and equivalents significantly increased to $1,832.7 million as of June 27, 2025, providing strong liquidity.
  • The company is actively returning capital to shareholders through share repurchase programs, including a new special purpose program of up to $550 million.
  • Favorable pricing contributed 2.9% to sales in Q2 2025 and 2.4% year-to-date, including countermeasures against tariffs.
  • The Intelligent Operating Solutions (IOS) segment saw volume increases in gas detection offerings and growth in North America for facility and asset lifecycle SaaS products.
  • The Precision Technologies (PT) segment experienced increased demand in the utilities sector for grid modernization.
  • The Advanced Healthcare Solutions (AHS) segment saw volume increases in software products and dosimetry services, with increased demand in North America healthcare software.

Negatives

  • Total sales decreased by 2.2% in Q2 2025 and 2.7% year-to-date compared to the prior year periods.
  • Core revenue declined by 2.5% in Q2 2025 and 2.1% year-to-date, primarily due to volume declines of 5.4% and 4.5% respectively.
  • Net earnings decreased by 14.6% in Q2 2025 and 15.9% year-to-date.
  • Operating profit decreased significantly by 26.4% in Q2 2025 and 24.5% year-to-date.
  • Operating profit margin declined by 480 basis points in Q2 2025 and 440 basis points year-to-date.
  • Selling, general and administrative (SG&A) expenses increased by 7.4% in Q2 2025 and 1.8% year-to-date, largely due to Separation-related costs and higher employee compensation.
  • Research and development (R&D) expenses increased by 8.0% in Q2 2025 and 4.4% year-to-date due to ongoing investments and higher compensation.
  • The Precision Technologies (PT) segment experienced core revenue declines of 5.3% in Q2 2025 and 6.9% year-to-date, with volume reductions in test and measurement, energetic materials, and industrial sensing products.
  • The Advanced Healthcare Solutions (AHS) segment saw declines in sterilization healthcare equipment and biomedical test tools, with weakness in Latin America and Western Europe.
  • The year-over-year decrease in gross profit was due to overall volume decline, higher employee compensation, discrete restructuring charges, and unfavorable tariff impacts.
  • The effective tax rate increased for the six-month period ended June 27, 2025, compared to the prior year, primarily due to a discrete tax credit from cash repatriation in the comparable prior year period.

Risks

  • Conditions in the global economy, served markets, and financial markets may adversely affect business and financial results.
  • Inability to adjust manufacturing capacity, supply chain management, or purchases to reflect market changes, customer demand, and supply chain disruptions could harm profitability.
  • Reliance upon sole or limited sources of supply for certain materials, components, and services could cause production interruptions, delays, and inefficiencies.
  • Fluctuations in the cost and availability of commodities or components used in operations.
  • Growth could suffer if markets decline, do not grow as anticipated, or experience cyclicality.
  • Intense competition may lead to decreased demand, market share, or require price reductions.
  • Dependence on timely development, commercialization, and customer acceptance of new products and services based on technological innovation.
  • Ability to attract, develop, and retain senior leaders and other key employees is critical to success.
  • Disruptions in, or breaches in security of, information technology systems could adversely affect business.
  • Defects and unanticipated use or inadequate disclosure with respect to products (including software) or services could adversely affect business, reputation, and financial results.
  • Adverse changes in relationships with, or financial condition, performance, purchasing patterns, or inventory levels of, key distributors and other channel partners.
  • Restructuring activities could have long-term adverse effects on the business.
  • Work stoppages, works council campaigns, and other labor disputes could adversely impact productivity and results of operations.
  • Loss to facilities, supply chains, distribution systems, or information technology systems due to catastrophe or other events could seriously harm operations.
  • Inadequate protection or infringement of intellectual property rights could lead to competitive injury or significant enforcement resources.
  • Third parties claiming infringement or misappropriation of intellectual property rights could result in significant litigation expenses, losses, or licensing expenses.
  • Subject to a variety of litigation and other legal and regulatory proceedings.
  • Climate change, or legal or regulatory measures to address climate change, may negatively affect the company.
  • Challenges with properly managing the use of artificial intelligence could result in reputational harm, competitive harm, and legal liability.
  • International economic, political, legal, trade policies, compliance, and business factors could negatively affect financial results.
  • Trade relations between the United States and other countries, including new or increased tariffs and related uncertainty, could have a material adverse effect.
  • Foreign currency exchange rates, including volatility, may adversely affect financial results.
  • Inability to consummate acquisitions at anticipated rates and prices, and to make appropriate investments, could negatively impact growth rate and stock price.
  • Acquisition of businesses, investments, joint ventures, and other strategic relationships could negatively impact financial results.
  • Indemnification provisions of acquisition agreements may not fully protect against unexpected liabilities.
  • Divestitures or other dispositions could negatively impact the business, and contingent liabilities from sold businesses could adversely affect financial results.
  • Potential indemnification liabilities to Ralliant Corporation and Vontier Corporation pursuant to separation agreements could materially and adversely affect businesses, financial condition, results of operations, and cash flows.
  • Changes in industry standards and governmental regulations may reduce demand or increase expenses.
  • Reputation, ability to do business, and financial results may be impaired by improper conduct by employees, agents, or business partners.
  • Operations, products, and services expose the company to environmental, health, and safety liabilities, costs, and violations.
  • Businesses are subject to extensive regulation, including healthcare regulations; failure to comply could adversely affect financial results and reputation.
  • Changes in effective tax rates or exposure to additional tax liabilities or assessments could affect profitability, and audits by tax authorities could result in additional tax payments.
  • Significant liability could be incurred if separation transactions (Danaher, Automation and Specialty, Ralliant, Vontier) are determined to be taxable.
  • Changes in U.S. GAAP could adversely affect reported financial results and require significant changes to internal accounting systems and processes.
  • May be required to recognize impairment charges for goodwill and other intangible assets.
  • Incurred a significant amount of debt, and debt obligations, including cost, will increase further if additional debt is incurred, existing debt is not retired, credit rating declines, or applicable interest rates rise.

Future Outlook

The company expects foreign exchange rates to remain volatile throughout the year, potentially impacting financial results. The financial outlook is subject to various assumptions and risks, including ongoing geopolitical developments, uncertainties related to governmental policies on international trade and healthcare, monetary and fiscal policies (including tariffs and the recently enacted One Big Beautiful Bill Act (OBBBA)), increased economic nationalism, macroeconomic conditions in key regions, and the impact of inflationary dynamics on expenses or pricing. The company will continue to deploy the Fortive Business System (FBS) tools and processes to manage these challenges through pricing, cost, and productivity actions.

Management Comments

  • Our businesses are affected by worldwide, regional, and industry-specific economic, regulatory, and political factors.
  • Our geographic and industry diversity, as well as the range of products, software, and services we offer, typically help limit the impact of any one industry or the economy of any single country (except for the United States) on our operating results.
  • We do not use any indices other than general economic trends to predict the overall outlook for the Company.
  • Our long-term growth and profitability will depend on our ability to expand business across geographies and market segments, identify, consummate, and integrate appropriate acquisitions, develop innovative and differentiated new products, services, and software, expand and improve the effectiveness of our sales force, continue to reduce costs and improve operating efficiency and quality, attract relevant talent and retain, grow, and empower our talented workforce, and effectively address the demands of an increasingly regulated environment.
  • We are making significant investments, organically and through acquisitions, to address technological change in the markets we serve and to improve our manufacturing, research and development, and customer-facing resources.
  • We continue to evaluate the impact of tariffs on our financial results, as the application and imposition of these tariffs remains unpredictable.
  • We expect to have sufficient liquidity to satisfy our cash needs for the foreseeable future.

Industry Context

The company operates in a highly competitive business environment across its diverse end-markets, including manufacturing, healthcare, utilities, and electronics. The ongoing global economic uncertainties, trade policy shifts (like tariffs), and inflationary pressures are affecting demand and costs across these sectors. The strategic separation of the Precision Technologies segment into Ralliant Corporation reflects a broader industry trend towards specialization and optimizing portfolio focus, aiming to unlock value by allowing each entity to pursue distinct strategic priorities. The company's continued investment in R&D and its Fortive Business System (FBS) initiatives are critical for maintaining competitiveness and adapting to technological changes and market demands, particularly in areas like electrification and connectivity.

Comparison to Industry Standards

  • NA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Share Repurchase Program Authorization IncreaseThe Board of Directors increased the number of shares authorized under the general share repurchase program by an additional 15.6 million shares.2025-05-27Expands the company's capacity to return capital to shareholders, potentially supporting share price and improving EPS through reduced share count.
Special Purpose Share Repurchase Program AdoptionThe Board of Directors adopted a separate special purpose share repurchase program for up to $550 million, exclusively from the proceeds of the Ralliant Dividend.2025-05-27Provides a dedicated mechanism to utilize proceeds from the Ralliant separation for shareholder returns, signaling confidence in capital allocation strategy.

Related Party Transactions

  • A charitable contribution of $20 million was pledged to the Fortive Foundation on March 14, 2024, which is a related party due to certain Fortive executives serving as board members.

Stakeholder Impact

  • Shareholders: Impacted by declining net earnings and EPS, but also benefit from ongoing share repurchase programs and the strategic separation of the PT segment, which aims to unlock long-term value.
  • Employees: Affected by targeted workforce reductions as part of the discrete restructuring plan related to the Separation.
  • Customers: May experience impacts from volume declines in certain product lines and segments, but the company continues to invest in innovation and customer-facing resources.
  • Creditors: The company's debt obligations have increased with the Ralliant Debt, but proceeds were used to repay existing debt, indicating active debt management. The company maintains access to credit facilities and capital markets.

Next Steps

  • Ralliant Corporation will be classified as a discontinued operation in financial statements beginning with the third quarter of 2025.
  • Fortive intends to apply the Ralliant Dividend proceeds to repurchase certain of its outstanding common stock pursuant to the special purpose share repurchase program authorized on May 27, 2025.
  • The company will continue to evaluate the impact of tariffs on financial results, as their application and imposition remain unpredictable.
  • The company is assessing the potential impact of the One Big Beautiful Bill Act (OBBBA) on its consolidated financial statements and tax strategies.
  • The company will update applicable annual disclosures to align with the new FASB ASU 2023-09 standard, effective for fiscal year ending December 31, 2025.
  • The company will update applicable interim and annual disclosures to align with the new FASB ASU 2024-03 standard upon its adoption, effective for fiscal year ending December 31, 2027, and interim periods within fiscal year ending December 31, 2028.

Key Dates

DateDescription
2023-12-31Effective date for FASB ASU 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosures, which amends certain disclosure requirements related to income taxes on an annual basis.
2024-01-03Acquisition of EA Elektro-Automatik Holding GmbH completed.
2024-01-23Board of Directors increased shares authorized under the general share repurchase program by an additional 11 million shares.
2024-02-13Completion of the sale of 2026 Notes and 2029 Notes, yielding net proceeds of approximately $1.3 billion. Repayment of $1.0 billion in outstanding principal of the Delayed-Draw Term Loan due 2024.
2024-03-14Sale of land and certain office buildings in the PT segment for $90 million, resulting in a $63.1 million gain on sale of property.
2024-06-04Maturity date of the Yen Term Loan due on June 17, 2025, extended to December 31, 2025.
2024-06-17Maturity date of the Euro Term Loan due on June 23, 2025, extended to December 31, 2025.
2024-06-28Invetech Divestiture completed, resulting in a net realized loss of $25.6 million. Also, the Distribution Date for the separation of the Precision Technologies segment (Ralliant Corporation).
2024-11-01Effective date for FASB ASU 2024-03, Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses, which amends disclosure requirements related to certain costs and expenses on an interim and annual basis.
2024-12-31Expected completion date for the discrete restructuring plan initiated in Q4 2024.
2025-05-15Ralliant entered into a credit agreement for a three-year, $700 million senior unsecured delayed draw term loan facility, an eighteen-month, $600 million senior unsecured delayed draw term loan facility, and a five-year $750 million unsecured revolving credit facility.
2025-05-27Board of Directors increased shares authorized under the general share repurchase program by an additional 15.6 million shares. Also, adopted a separate special purpose share repurchase program for up to $550 million using Ralliant Dividend proceeds.
2025-06-16Record date for the distribution of Ralliant Corporation common stock to Fortive shareholders.
2025-06-27End of the quarterly period covered by this report. Ralliant borrowed $1.15 billion in aggregate principal amount of USD Term Loans due 2026 and 2028, paid as a cash dividend to Fortive.
2025-07-04The One Big Beautiful Bill Act (OBBBA) enacted in the U.S., resulting in significant income tax provisions with effective dates spanning from 2025 through 2027.
2025-07-15Fortive used approximately $302 million of the Ralliant Dividend to redeem 252 million of the outstanding principal of the 3.7% Euro-denominated senior unsecured notes due 2026.
2025-07-24Fortive used $324 million of the Ralliant Dividend to repay the outstanding principal of the Euro Term Loan.
2025-07-25Fortive used $98 million of the Ralliant Dividend to repay the outstanding principal of the Yen Term Loan.
2025-07-30Date of filing of this Quarterly Report on Form 10-Q.
2025-08-01Temporary pause on certain tariffs from the U.S. government is expected to end.
2027-10-18Expiration date of the five-year $2.0 billion senior unsecured revolving credit facility.
2027-12-31Effective date for FASB ASU 2024-03, Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses, for fiscal year ending.
2028-12-31Effective date for FASB ASU 2024-03, Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses, for interim periods within fiscal year ending.

Recommendation

hold

Fortive is undergoing a significant strategic transformation with the separation of its Precision Technologies segment. While the current quarter shows declines in sales, net earnings, and operating profit, largely due to volume softness and substantial separation-related costs, the company is actively managing its capital structure by reducing debt and executing share repurchases. The long-term implications of the PT separation, including the reclassification of Ralliant as a discontinued operation, will reshape Fortive's financial profile. A 'hold' recommendation is appropriate for a seasoned investor, as it allows for observation of the company's performance post-separation and the realization of anticipated strategic benefits, while acknowledging the current headwinds.

Keywords

Industrial Technology, Healthcare Solutions, Precision Technologies, Intelligent Operating Solutions, SEC Filing, 10-Q, Financial Results, Earnings, Revenue, Operating Profit, Cash Flow, Divestiture, Acquisition, Ralliant Separation, Share Repurchase, Debt Management, Tariffs, Supply Chain, Corporate Governance, Risk Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.